Inhibition of Type a Monoamine Oxidase by 2(N)-Methyl-6,7-dihydroxyisoquinolinium Ions
M NAOI,W MARUYAMA,S SASUGA,YL DENG,P DOSTERT,S OHTA,T TAKAHASHI
DOI: https://doi.org/10.1016/0197-0186(94)90024-8
IF: 4.297
1994-01-01
Neurochemistry International
Abstract:In the human brain, monoamine-derived 6,7-dihydroxy-1,2,3,4-tetrahydroisoquinolines and 1,2,3,4-tetrahydroisoquinolines have been identified and their enzymatic methylation into N(2)-methylisoquinolines has been also confirmed. N-methylated 6,7-dihydroxyisoquinolines were found to be oxidized into 6,7-dihydroxy-N-methylisoquinolinium ions. The effects of the isoquinolinium ions on type A and B monoamine oxidase were examined, using enzyme samples isolated from human brain synaptosomal mitochondria. 1,2-Dimethyl-6,7-dihydroxyisoquinolinium ion (N-methylsalsolinium ion) and 2-methyl-6,7-dihydroxyisoquinolinium ion (N-methylnorsalsolinium ion), were found to be potent inhibitors of type A monoamine oxidase. The inhibition was competitive to the substrate, while the isoquinolinium ions were much weaker inhibitors of type B and the inhibition was non-competitive to the substrate. Isoquinolinium ions without catechol structure, N(2)-methylisoquinolinium ion and 1,2-dimethylisoquinolinium ion also inhibited both type A and B monoamine oxidase. 1,2-Dimethylisoquinolinium was the most potent inhibitor among examined isoquinolines, followed by the N-methylsalsolinium ion. The activity-structure relationship of the isoquinolines with and without catechol structure was examined in terms of potency and selectivity of the inhibition to type A and B monoamine oxidase. Catechol structure was found to increase the selectivity of inhibition to type A, as shown by comparison of N-methylsalsolinium ion with 1,2-dimethylisoquinolinium ion. N-Methylsalsolinium ion inhibited type A MAO more selectively than 1,2-dimethylisoquinolinium ion, which inhibited type A and type B with almost the same values of the inhibitor constant. The selective inhibition of type A monoamine oxidase by catechol isoquinolinium ions may have an important role in the brain function, since the substrates of type A monoamine oxidase are major neurotransmitters in the brain, such as serotonin and norepinephrine. The inhibition of monoamine oxidase by isoquinolinium ions may perturb the levels and function of the monoamines in the brain under physiological and pathological conditions.